The new report reveals that many of the authors and reviewers have been outspoken critics of gender-affirming care and belong ...

Pfizer and Tris Pharma agreed to pay $41.5 million to settle allegations they altered testing methods to ensure their ADHD ...

Function Health, a provider of lab testing and other services, announced on Wednesday $298 million in new funding with plans ...

WASHINGTON — Prospects are not looking good for an extension of the extra tax credits that have helped more Americans buy insurance plans in the Affordable Care Act’s marketplaces. Republicans don’t ...

The liability, safety, and accuracy questions underlying one creative proposal, in this week's AI Prognosis newsletter.

Novo Nordisk is set to soon unveil pivotal Phase 3 data on whether semaglutide — the blockbuster GLP-1 drug behind Ozempic ...

Novo Nordisk is expected to announce soon whether its blockbuster GLP-1 drug semaglutide can help slow Alzheimer’s disease ...

Agios reported mixed results from a Phase 3 study of its drug Pyrukynd in sickle cell, raising doubts about the drug's ...

In a first-of-its-kind randomized trial, people who smoked weed consumed less alcohol in the two hours afterward than those ...

Also, we report on some dramatic new childhood vaccine policies that are under consideration, and see how few lower- and ...

A federal bankruptcy court judge on Tuesday formally approved OxyContin maker Purdue Pharma’s plan to settle thousands of ...

Every physician needs to have a basic level of AI literacy now. That might require some sort of licensing exam.